Overview

A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased

Status:
Completed

Trial end date:
2004-10-01

Target enrollment:

Participant gender:

Summary

This is a multicentre, randomized, double-blind, placebo controlled study. During this study all the patients will receive background venous thromboembolism (VTE) mechanical prophylaxis with intermittent pneumatic compression (IPC).

Phase:

Phase 3

Details

Lead Sponsor:

GlaxoSmithKline

Collaborator:

Sanofi

Treatments:

Fondaparinux
PENTA